Arvinas (ARVN) EBIT Margin Growth (1y) (2018 - 2026)
Powered by 
Analysis
Arvinas (ARVN) EBIT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -1,651.00 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 29,091.00 |
| 10 | Arvinas | 605.88 Mn | 37.98 Mn | - | 38,492.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38,492.00 |
| Mar 31, 2026 | -44,679.00 |
| Dec 31, 2025 | -68,695.00 |
| Sep 30, 2025 | -4,565.00 |
| Jun 30, 2025 | -25,580.00 |
| Mar 31, 2025 | 36,707.00 |
| Dec 31, 2024 | -48,184.00 |
| Sep 30, 2024 | 15,470.00 |
| Jun 30, 2024 | 7,348.00 |
| Mar 31, 2024 | -5,940.00 |
| Dec 31, 2023 | 58,353.00 |
| Sep 30, 2023 | -1,991.00 |
| Jun 30, 2023 | 5,779.00 |
| Mar 31, 2023 | -5,211.00 |
| Dec 31, 2022 | -5,693.00 |
| Sep 30, 2022 | 31,493.00 |
| Jun 30, 2022 | 74,896.00 |
| Mar 31, 2022 | 54,045.00 |
| Dec 31, 2021 | 47,689.00 |
| Sep 30, 2021 | -9,069.00 |